Article

Rapid pink-eye tests are now available in one state

MinuteClinic now offers a rapid conjunctivitis test at its 23 locations inside select pharmacy stores in the Atlanta area, according to a prepared statement.

Atlanta

-MinuteClinic now offers a rapid conjunctivitis test at its 23 locations inside select pharmacy stores in the Atlanta area, according to a prepared statement.

The clinic’s nurse practitioners can use the test to diagnose accurately whether a patient has viral or bacterial conjunctivitis, and then practitioners can identify an appropriate course of treatment, eliminating unnecessary antibiotic prescriptions, the company said.

“MinuteClinic patients will get on-the-spot results that provide a more precise pink-eye diagnosis,” said Donna Haugland, MinuteClinic chief nursing officer. “This helps prevent the overuse of antibiotics and can lead to prescription savings.”

Although treatment for conjunctivitis with antibiotics is necessary in only 40% to 60% of cases, the majority of medical professionals prescribe antibiotics nearly 100% of the time, according to the release.

“Our goal was to develop new medical technology that improves patient outcomes and results in the highest level of care,” said Robert Sambursky, MD, chief medical officer for Rapid Pathogen Screening (RPS) Inc. “The [test] gives medical professionals a safe, convenient, and affordable option to diagnose pink eye.”

The test is a pilot project conducted in partnership with RPS, and MinuteClinic said that it hopes to offer the test nationally at a future date in its clinic locations in 25 states.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.